논문 목록
10건 · 최신순- Commentary on: Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are You Covered?
-
Risk Factor Analysis for Capsular Contracture, Malposition, and Late Seroma in Subjects Receiving Natrelle 410 Form-Stable Silicone Breast Implants.
[BACKGROUND] Natrelle 410 silicone breast implants are approved in the United States for breast augmentation, reconstruction, and revision. [METHODS] In two ongoing, prospective, multicenter 10-year studies, 17,656 subjects received Natrel…
-
Medicolegal Issues in Breast Reduction.
Areas of general risk are discussed with patients before surgery. Procedure-specific risks inherent in each technique are a key part of informed consent. Issues related to insurance coverage must be settled preoperatively to decrease litiga…
-
A systematic examination of the effect of tissue glues on rhytidectomy complications.
[BACKGROUND] Fibrin glue has widespread use in multiple fields of surgery. There have been numerous studies on the use of fibrin glue in facelifts, with no consensus regarding differences in outcomes. [OBJECTIVES] This study compared the r…
- Breast Implant-Associated Anaplastic Large Cell Lymphoma: What We Can Do.
-
Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients.
[UNLABELLED] Breast implant-associated anaplastic large cell lymphoma (BIA ALCL) is a newly described clinicopathologic entity. The purpose of this study is to describe the imaging findings of patients with BIA ALCL and determine their sens…
-
Clinical trial outcomes of high- and extra high-profile breast implants.
[BACKGROUND] Clinical data concerning potential risks and benefits associated with the use of high- and extra high-profile breast implants are lacking. [OBJECTIVES] The authors assess the risk of adverse events (AE) with high- and extra hi…
-
Ethics, legal issues, and consent for fillers.
The huge patient demand for filler rejuvenation exposes plastic surgeons to legal issues. Plastic surgery statistics confirm a trend toward nonsurgical procedures, with a slight increase in surgical procedures overall from 2004 to 2005. Non…
-
Decision and management algorithms to address patient and food and drug administration concerns regarding breast augmentation and implants.
During the U.S. Food and Drug Administration's advisory panel hearings to evaluate the premarket approval for conventional silicone gel implants on October 14 and 15, 2003, panel members and patient advocate representatives focused on four …
- Use of off-label and non-approved drugs and devices in plastic surgery.